Drug metabolism by Escherichia coli expressing human cytochromes P450. Parikh A, Gillam EM, Guengerich FP (1997) Nat Biotechnol 15: 784-8 Evolutionarily divergent electron donor proteins interact with P450MT2 through the same helical domain but different contact points. Anandatheerthavarada HK, Amuthan G, Biswas G, Robin MA, Murali R, Waterman MR, Avadhani NG (2001) EMBO J 20: 2394-403 Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR (1996) Cancer Res 56: 2979-84 Expression of drug-metabolizing enzymes. Guengerich FP, Parikh A (1997) Curr Opin Biotechnol 8: 623-8 Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients. Sahakitrungruang T, Huang N, Tee MK, Agrawal V, Russell WE, Crock P, Murphy N, Migeon CJ, Miller WL (2009) J Clin Endocrinol Metab 94: 4992-5000 A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases. Lamb DC, Kim Y, Yermalitskaya LV, Yermalitsky VN, Lepesheva GI, Kelly SL, Waterman MR, Podust LM (2006) Structure 14: 51-61 Flavodoxin as a model for the P450-interacting domain of NADPH cytochrome P450 reductase. Jenkins CM, Waterman MR (1999) Drug Metab Rev 31: 195-203 N-hydroxyarylamines. Guengerich FP (2002) Drug Metab Rev 34: 607-23 Developmentally regulated expression of adrenal 17 alpha-hydroxylase cytochrome P450 in the mouse embryo. Keeney DS, Jenkins CM, Waterman MR (1995) Endocrinology 136: 4872-9 Cytochromes P-450scc, P-450(17)alpha, adrenodoxin, and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase in bovine follicles and corpora lutea. Changes in specific contents during the ovarian cycle. Rodgers RJ, Waterman MR, Simpson ER (1986) Endocrinology 118: 1366-74 Flavodoxin and NADPH-flavodoxin reductase from Escherichia coli support bovine cytochrome P450c17 hydroxylase activities. Jenkins CM, Waterman MR (1994) J Biol Chem 269: 27401-8 Partitioning between N-dealkylation and N-oxygenation in the oxidation of N,N-dialkylarylamines catalyzed by cytochrome P450 2B1. Seto Y, Guengerich FP (1993) J Biol Chem 268: 9986-97 Stimulation of cytochrome P450 reactions by apo-cytochrome b5: evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5 or heme oxygenase. Yamazaki H, Shimada T, Martin MV, Guengerich FP (2001) J Biol Chem 276: 30885-91 Evidence for the presence of cholesterol side chain cleavage cytochrome P-450 and adrenodoxin in fresh granulosa cells. Effects of follicle-stimulating hormone and cyclic AMP on cholesterol side chain cleavage cytochrome P-450 synthesis and activity. Funkenstein B, Waterman MR, Masters BS, Simpson ER (1983) J Biol Chem 258: 10187-91 Kinetic processivity of the two-step oxidations of progesterone and pregnenolone to androgens by human cytochrome P450 17A1. Gonzalez E, Guengerich FP (2017) J Biol Chem 292: 13168-13185 Geldanamycin leads to superoxide formation by enzymatic and non-enzymatic redox cycling. Implications for studies of Hsp90 and endothelial cell nitric-oxide synthase. Dikalov S, Landmesser U, Harrison DG (2002) J Biol Chem 277: 25480-5 The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3. Capdevila JH, Wei S, Helvig C, Falck JR, Belosludtsev Y, Truan G, Graham-Lorence SE, Peterson JA (1996) J Biol Chem 271: 22663-71 An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S,15R)-arachidonic acid epoxygenase. Graham-Lorence S, Truan G, Peterson JA, Falck JR, Wei S, Helvig C, Capdevila JH (1997) J Biol Chem 272: 1127-35 Expression and purification of functional human 17 alpha-hydroxylase/17,20-lyase (P450c17) in Escherichia coli. Use of this system for study of a novel form of combined 17 alpha-hydroxylase/17,20-lyase deficiency. Imai T, Globerman H, Gertner JM, Kagawa N, Waterman MR (1993) J Biol Chem 268: 19681-9 Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6. Lack of an allosteric role of NADPH-cytochrome P450 reductase in catalytic regioselectivity. Hanna IH, Krauser JA, Cai H, Kim MS, Guengerich FP (2001) J Biol Chem 276: 39553-61 Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. Henderson CJ, Otto DM, Carrie D, Magnuson MA, McLaren AW, Rosewell I, Wolf CR (2003) J Biol Chem 278: 13480-6 Lack of electron transfer from cytochrome b5 in stimulation of catalytic activities of cytochrome P450 3A4. Characterization of a reconstituted cytochrome P450 3A4/NADPH-cytochrome P450 reductase system and studies with apo-cytochrome b5. Yamazaki H, Johnson WW, Ueng YF, Shimada T, Guengerich FP (1996) J Biol Chem 271: 27438-44 Lanosterol 14alpha-demethylase (CYP51), NADPH-cytochrome P450 reductase and squalene synthase in spermatogenesis: late spermatids of the rat express proteins needed to synthesize follicular fluid meiosis activating sterol. Majdic G, Parvinen M, Bellamine A, Harwood HJ, Ku WW, Waterman MR, Rozman D (2000) J Endocrinol 166: 463-74 Levels of adrenodoxin, NADPH-cytochrome P-450 reductase and cytochromes P-45011 beta, P-45021, P-450scc, in adrenal zona fasciculata-reticularis tissue from androgen-treated rats. Brownie AC, Bhasker CR, Waterman MR (1988) Mol Cell Endocrinol 55: 15-20 Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102. Lewis DF, Lake BG, George SG, Dickins M, Eddershaw PJ, Tarbit MH, Beresford AP, Goldfarb PS, Guengerich FP (1999) Toxicology 139: 53-79 Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1. Yamazaki H, Hatanaka N, Kizu R, Hayakawa K, Shimada N, Guengerich FP, Nakajima M, Yokoi T (2000) Mutat Res 472: 129-38 Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase. Aryal P, Yoshikawa K, Terashita T, Guengerich FP, Shimada T, Oda Y (1999) Mutat Res 442: 113-20 Metabolic activation of carcinogenic 1-nitropyrene by human cytochrome P450 1B1 in Salmonella typhimurium strain expressing an O-acetyltransferase in SOS/umu assay. Hatanaka N, Yamazaki H, Oda Y, Guengerich FP, Nakajima M, Yokoi T (2001) Mutat Res 497: 223-33 Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase. Oda Y, Aryal P, Terashita T, Gillam EM, Guengerich FP, Shimada T (2001) Mutat Res 492: 81-90 Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/umu assay. Aryal P, Terashita T, Guengerich FP, Shimada T, Oda Y (2000) Environ Mol Mutagen 36: 121-6 Formation and reduction of aryl and heterocyclic nitroso compounds and significance in the flux of hydroxylamines. Kim D, Kadlubar FF, Teitel CH, Guengerich FP (2004) Chem Res Toxicol 17: 529-36 Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli. Josephy PD, Evans DH, Parikh A, Guengerich FP (1998) Chem Res Toxicol 11: 70-4 Regioselective differences in C(8)- and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2. Turesky RJ, Parisod V, Huynh-Ba T, Langouët S, Guengerich FP (2001) Chem Res Toxicol 14: 901-11 Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH--cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates. Yamazaki H, Ueng YF, Shimada T, Guengerich FP (1995) Biochemistry 34: 8380-9 Oxidation of indole by cytochrome P450 enzymes. Gillam EM, Notley LM, Cai H, De Voss JJ, Guengerich FP (2000) Biochemistry 39: 13817-24 NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase. Jenkins CM, Waterman MR (1998) Biochemistry 37: 6106-13 Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties. Parikh A, Josephy PD, Guengerich FP (1999) Biochemistry 38: 5283-9 Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems. Guengerich FP, Johnson WW (1997) Biochemistry 36: 14741-50 Reduction of cytochrome b5 by NADPH-cytochrome P450 reductase. Guengerich FP (2005) Arch Biochem Biophys 440: 204-11 Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5. Shaw PM, Hosea NA, Thompson DV, Lenius JM, Guengerich FP (1997) Arch Biochem Biophys 348: 107-15
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.